/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo
Kristin Houser

Kristin Houser

Staff Writer

Latest Stories

Nepmoon
2.21.19, 9:46 AM EST on the byte
Meet Hippocamp, “The Moon That Shouldn’t Be There”
Danger Ahead
2.20.19, 1:57 PM EST on neoscope
EPA: Low Doses of Toxins, Radiation Could Actually Be Healthy
Muskcoin
2.20.19, 11:12 AM EST on futurism
Elon Musk: Bitcoin Is "Brilliant" And "Paper Money Is Going Away"
Stellar Stream
2.20.19, 9:22 AM EST on the byte
Scientists Found a “River of Stars” Flowing Through the Milky Way
Weed Need
2.19.19, 4:57 PM EST on neoscope
WHO Says UN Should Reclassify Marijuana as Less Dangerous
Sorry, Cows
2.19.19, 3:08 PM EST on the byte
Lab-Grown Meat Could Be Worse for the Environment
¯\_(ツ)_/¯
Updated 2.19.19, 1:39 PM EST on the byte
Judges Are Struggling to Interpret Emoji in Court Cases
Galaxy Quest
2.19.19, 11:39 AM EST on the byte
Scientists Just Discovered 300,000 New Galaxies
Float On
Updated 2.16.19, 12:12 PM EST on the byte
Ride out Climate Change in This $5.5 Million Self-Sustaining Yacht
Seeing Double
Updated 2.15.19, 4:16 PM EST on the byte
Scientist Defends Controversial Cloning of Gene-Edited Monkeys
Tesla Tech
2.15.19, 3:43 PM EST on the byte
Tesla's Anti-ICEing System Just Got an Upgrade
One Down
2.15.19, 11:42 AM EST on neoscope
Anti-Aging Drug That Kills Old Cells Passes First Human Trial
  • Previous
  • 1
  • ...
  • 91
  • 92
  • 93
  • ...
  • 221
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.